Below is our "Chart of the Day" from today's Early Look written by our Risk-Manager-In-Chief Keith McCullough detailing Health Care analyst Tom Tobin's EPIC short call on 10x Genomics (TXG).

TXG missed 3Q24 earnings this morning sending the stock plummeting -26% in pre-market trading.
 
Tobin has been short TXG since March 2022, riding it down from $70 after being bullish on its way up to $202 in 2021.
 
According to Tobin, "The worst part hasn't even happened yet." CLICK HERE to get more Health Care research and follow all new developments.

CHART OF THE DAY: Tobin Nails Short Call <abbr name='10x Genomics Inc.'>TXG</abbr> - txg


You're Leaving Hedgeye Risk Management...

By selecting this link, you are now leaving the Hedgeye Risk Management (“HRM”) website. The following website contains information concerning investment products managed by Hedgeye Asset Management (“HAM”), an affiliate of HRM, or a firm partnering with HAM, and is subject to HAM’s Privacy Policy. As a separate legal entity, all HAM asset management services are made independently by portfolio managers at HAM and, as such, funds may vary from HRM research.

HRM is not responsible for the accuracy or completeness of information on external websites. HRM does not make any representation regarding the advisability of investing in any investment product or any particular investment advisory. Any opinions or recommendations from linked websites are solely those of our affiliate and are not the opinions or recommendations of HRM.

HRM DOES NOT PROVIDE PERSONALIZED INVESTMENT ADVICE OR ENGAGE IN ANY ASSET MANAGEMENT SERVICE. LASTLY, THIS LINK IS NOT AN OFFER TO BUY OR A SOLICITATION TO SELL ANY SECURITY OR INVESTMENT PRODUCT, OR THE SOLICITATION OF ANY ADVISORY SERVICES.